Debt-to-equity of Akebia Therapeutics, Inc. from 30 Sep 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Akebia Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 31 Dec 2025.
  • Akebia Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 991%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Akebia Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 991% +1635% 31 Dec 2025
Q3 2025 2585% +3315% 30 Sep 2025
Q2 2025 -2467% -1663% -207% 30 Jun 2025
Q1 2025 -981% -111% -13% 31 Mar 2025
Q4 2024 -644% +328% +34% 31 Dec 2024
Q3 2024 -730% +775% +52% 30 Sep 2024
Q2 2024 -804% +3411% +81% 30 Jun 2024
Q1 2024 -870% -3793% -130% 31 Mar 2024
Q4 2023 -972% -2843% -152% 31 Dec 2023
Q3 2023 -1505% -2654% -231% 30 Sep 2023
Q2 2023 -4215% -4868% -746% 30 Jun 2023
Q1 2023 2923% +2463% +536% 31 Mar 2023
Q4 2022 1870% +1575% +533% 31 Dec 2022
Q3 2022 1149% +926% +416% 30 Sep 2022
Q2 2022 653% +484% +286% 30 Jun 2022
Q1 2022 460% +325% +241% 31 Mar 2022
Q4 2021 296% +181% +158% 31 Dec 2021
Q3 2021 223% +121% +119% 30 Sep 2021
Q2 2021 169% +79% +87% 30 Jun 2021
Q1 2021 135% +56% +71% 31 Mar 2021
Q4 2020 114% +46% +67% 31 Dec 2020
Q3 2020 102% +41% +69% 30 Sep 2020
Q2 2020 90% +23% +35% 30 Jun 2020
Q1 2020 79% -0.24% -0.31% 31 Mar 2020
Q4 2019 68% -29% -30% 31 Dec 2019
Q3 2019 60% -98% -62% 30 Sep 2019
Q2 2019 67% -99% -60% 30 Jun 2019
Q1 2019 79% -132% -63% 31 Mar 2019
Q4 2018 98% -221% -69% 31 Dec 2018
Q3 2018 159% -224% -59% 30 Sep 2018
Q2 2018 166% -149% -47% 30 Jun 2018
Q1 2018 211% +33% +19% 31 Mar 2018
Q4 2017 319% +230% +260% 31 Dec 2017
Q3 2017 383% +346% +939% 30 Sep 2017
Q2 2017 315% +291% +1182% 30 Jun 2017
Q1 2017 178% +163% +1132% 31 Mar 2017
Q4 2016 89% +81% +1029% 31 Dec 2016
Q3 2016 37% +30% +408% 30 Sep 2016
Q2 2016 25% +18% +303% 30 Jun 2016
Q1 2016 14% +8.2% +131% 31 Mar 2016
Q4 2015 7.8% +2.6% +50% 31 Dec 2015
Q3 2015 7.3% -1.8% -20% 30 Sep 2015
Q2 2015 6.1% 30 Jun 2015
Q1 2015 6.2% 31 Mar 2015
Q4 2014 5.2% 31 Dec 2014
Q3 2014 9.1% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.